Login to Your Account

Week in Review

Monday, December 19, 2011


Ariad Pharmaceuticals Inc. raised $224 million in a public stock offering.

Cell Therapeutics Inc. is raising $20 million in a registered direct offering of stock and warrants.

Cerulean Pharma Inc. closed a $15 million Series D financing.

Ember Therapeutics raised $34 million in Series A financing for obesity and diabetes drugs.

ImmusanT Inc. raised $20 million in a Series A round for celiac disease vaccine Nexvax2.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription